Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials
Not yet recruiting
- Conditions
- Rectal Cancer
- Registration Number
- NCT05910099
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
The primary objective of this research study is to explore the barriers encountered by specific demographic groups of rectal cancer patients during the engagement in clinical trials, which historically lack diverse representation.
By carefully analyzing data from various demographic perspectives, this study aims to uncover patterns that impact the experiences of future rectal cancer patients. Active involvement in this crucial research is of utmost importance, as it can offer unique insights to enhance the participation and completion rates of rectal cancer patients in clinical study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Confirmed diagnosis of rectal cancer
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- No prior treatment for rectal cancer
Exclusion Criteria
- Pregnant or lactating woman
- Inability to provide written informed consent
- Enrolled in another research study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of rectal cancer patients who decide to participate in a clinical study 3 months Rate of patients who remain in a rectal cancer clinical study to completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States